Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1984 2
1990 2
1991 1
1992 3
1993 2
1994 2
1995 2
1996 4
1997 2
1998 5
1999 2
2000 5
2001 6
2002 11
2003 8
2004 12
2005 12
2006 13
2007 14
2008 9
2009 10
2010 14
2011 17
2012 16
2013 7
2014 8
2015 16
2016 17
2017 23
2018 29
2019 22
2020 17
2021 12
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Results by year

Filters applied: . Clear all
Page 1
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
Garrelfs SF, Frishberg Y, Hulton SA, Koren MJ, O'Riordan WD, Cochat P, Deschênes G, Shasha-Lavsky H, Saland JM, Van't Hoff WG, Fuster DG, Magen D, Moochhala SH, Schalk G, Simkova E, Groothoff JW, Sas DJ, Meliambro KA, Lu J, Sweetser MT, Garg PP, Vaishnaw AK, Gansner JM, McGregor TL, Lieske JC; ILLUMINATE-A Collaborators. Garrelfs SF, et al. Among authors: deschenes g. N Engl J Med. 2021 Apr 1;384(13):1216-1226. doi: 10.1056/NEJMoa2021712. N Engl J Med. 2021. PMID: 33789010 Clinical Trial.
Sodium-not harmful?
Deschênes G. Deschênes G. Pediatr Nephrol. 2020 Sep;35(9):1771-1776. doi: 10.1007/s00467-019-04356-x. Epub 2020 May 21. Pediatr Nephrol. 2020. PMID: 32440945
Collaboration between academics, small pharmaceutical company and patient organizations in the development of a new formulation of cysteamine in nephropathic cystinosis: A successful story.
Gaillard S, Roche L, Deschênes G, Morin D, Vianey-Saban C, Acquaviva-Bourdain C, Nony P, Subtil F, Mercier C, Cochat P, Bertholet-Thomas A, Cornu C, Kassai B. Gaillard S, et al. Among authors: deschenes g. Therapie. 2020 Apr;75(2):169-173. doi: 10.1016/j.therap.2020.02.008. Epub 2020 Feb 13. Therapie. 2020. PMID: 32248985 Review. French.
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.
Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschênes G, Lebranchu Y, Zuber J, Loirat C. Fremeaux-Bacchi V, et al. Among authors: deschenes g. Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10. Clin J Am Soc Nephrol. 2013. PMID: 23307876 Free PMC article.
Idiopathic nephrotic syndrome: the EBV hypothesis.
Dossier C, Jamin A, Deschênes G. Dossier C, et al. Among authors: deschenes g. Pediatr Res. 2017 Jan;81(1-2):233-239. doi: 10.1038/pr.2016.200. Epub 2016 Sep 28. Pediatr Res. 2017. PMID: 27682967 Review.
Steroid therapy in children with IgA nephropathy.
Cambier A, Boyer O, Deschenes G, Gleeson J, Couderc A, Hogan J, Robert T. Cambier A, et al. Among authors: deschenes g. Pediatr Nephrol. 2020 Mar;35(3):359-366. doi: 10.1007/s00467-018-4189-7. Epub 2019 Feb 18. Pediatr Nephrol. 2020. PMID: 30778826 Review.
[Postinfectious acute glomerulonephritis].
Garnier A, Peuchmaur M, Deschênes G. Garnier A, et al. Among authors: deschenes g. Nephrol Ther. 2009 Apr;5(2):97-101. doi: 10.1016/j.nephro.2008.06.001. Epub 2008 Sep 21. Nephrol Ther. 2009. PMID: 18809369 Review. French.
282 results